Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
SharonAI Tumbles 4.2% as Nvidia Pauses Cloud Financing, Clouding $4.88B Deal
SharonAI shares dropped 4.2% after Nvidia paused parts of a cloud financing initiative, raising questions about its $4.88 billion compute agreement.
Cytokinetics Drops 5% Despite Positive Phase 3 Data in nHCM
Cytokinetics shares slid 5% despite positive Phase 3 trial results for MYQORZO in non-obstructive HCM, as investors hoped for larger clinical benefits.
BioNTech Slumps 6.6% as Colorectal Cancer Vaccine Trial Halted
BioNTech shares dropped 6.6% after the company ended a Phase 2 trial of its colorectal cancer vaccine. The decision follows a data safety board recommendation and erases about $1.8 billion in market value.
Moderna Drops 3.4% on $2.6B Convertible Offering Amid Cancer Vaccine Rally
Moderna shares slid 3.4% to $137.86 after pricing a $2.6B zero-coupon convertible notes offering, sparking dilution worries and cooling the recent cancer-vaccine rally.
Roivant Dips 2.7% Despite FDA Nod for LISRAYA; JPMorgan Sees $2B Peak Sales
Roivant shares slipped 2.7% to $36.58 despite FDA approval of LISRAYA, the first oral treatment for dermatomyositis. JPMorgan sees peak U.S. sales exceeding $2 billion.
Kazia Therapeutics Slides 7.3% on $40M Equity Offering After Clinical Rally
Kazia Therapeutics shares dropped 7.3% after pricing a $40 million equity offering, capitalizing on a recent clinical data surge but diluting existing shareholders.
BioLineRx Plunges 20% on Dilutive $3.75M Offering
BioLineRx shares dropped 20% after a $3.75M offering priced at $2.78 per ADS, with warrants that could significantly increase dilution.
Quoin Rockets 42% on QRX003 Data, Unveils $50M Funding Plan
Quoin shares jumped 41.8% after QRX003 met its primary endpoint in an interim analysis. The company also announced a $50 million fundraising.
Marvell Stock Slides 6.9% as Google AI Revenue Shift Delays Boost to 2029
Marvell shares dropped 6.9% premarket after Google's AI revenue timeline pushed significant gains to fiscal 2029, despite record Q2 revenue.
PayPal Plunges 15% as $53B Acquisition Talks Collapse
PayPal shares tumbled 15.4% after dropping a $53 billion acquisition attempt, wiping out $8.1 billion in market value and raising growth concerns.
Founder Group Slumps 23% Premarket on Second Reverse Split
Founder Group shares fell 22.7% in premarket trading after the company revealed a second 100-for-1 reverse stock split, its second in seven months, set to take effect September 1.
E-Power Soars 23% on Record $51.1M Anode Contract
E-Power shares surged 23% premarket after securing a $51.1 million anode-line contract, which exceeds its 2025 revenue. The project adds 21,000 tons of annual capacity.